• Clinical Evidence

EndoTool Software for Tight Glucose Control for Critically Ill Patients

Setting: 874-bed regional academic medical center

Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results

  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.

Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.

Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results
  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.
Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.

References

Authors

Steven Cochran, MD; Edith Miller, MD; Kelli Dunn, MD; William Burgess, MD; William Miles, MD; Kevin Lobdell, MD.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 34, Issue 12, pA68.

Year

2006

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results
  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.
Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.

References

Authors

Steven Cochran, MD; Edith Miller, MD; Kelli Dunn, MD; William Burgess, MD; William Miles, MD; Kevin Lobdell, MD.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 34, Issue 12, pA68.

Year

2006

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.